Prolactin-induced expressionof cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors

Autor: E.L Hooghe-Peters, Shlomit Cwikel, Shoshana Merchav, Luba Prolov, Ilana Silvian-Drachsler
Přispěvatelé: Pharmacology, Vrije Universiteit Brussel
Jazyk: angličtina
Rok vydání: 2001
Předmět:
Cancer Research
Transcription
Genetic

medicine.medical_treatment
Antigens
CD34

Suppressor of Cytokine Signaling Proteins
chemistry.chemical_compound
STAT5 Transcription Factor
Receptor
Cells
Cultured

medicine.diagnostic_test
Reverse Transcriptase Polymerase Chain Reaction
Intracellular Signaling Peptides and Proteins
Hematology
Protein-Tyrosine Kinases
Fetal Blood
Milk Proteins
Recombinant Proteins
DNA-Binding Proteins
Haematopoiesis
Cytokine
Cord blood
hormones
hormone substitutes
and hormone antagonists

Signal Transduction
Biology
Immediate-Early Proteins
src Homology Domains
Suppressor of Cytokine Signaling 1 Protein
Western blot
Antigens
CD

Proto-Oncogene Proteins
Genetics
medicine
Humans
RNA
Messenger

Molecular Biology
Infant
Newborn

Tyrosine phosphorylation
Cell Biology
Janus Kinase 2
Hematopoietic Stem Cells
Molecular biology
Reverse transcriptase
In vitro
Prolactin
Repressor Proteins
chemistry
Gene Expression Regulation
Trans-Activators
Interleukin-3
Carrier Proteins
Popis: The prolactin (PRL) receptor (PRLR) utilizes the JAK2/STAT-5 pathway and induces expression of cytokine-inducible SH2 (CIS)/JAK2 binding (JAB) signaling inhibitors. We and others recently showed that CIS-3 and JAB abolish PRLR-mediated JAK2 activation and STAT-5 activity, whereas CIS-1, CIS-2, and CIS-4 had a negligible effect. Human CD34(+) hematopoietic progenitors express PRLRs and respond to PRL in vitro by enhanced cytokine-induced colony formation. To assess the signaling mechanism(s) involved in PRL-mediated enhancement of hematopoiesis and to identify further the CIS/JAB targets for PRL-mediated cellular responses, we assayed the effect of PRL, alone or in the presence of interleukin-3 (IL-3), on activation of STAT-5 and expression of CIS/JAB RNA in human cord blood (CB) CD34(+) cells.Isolated CB CD34(+) cells were incubated in serum-free cultures in the absence or presence of recombinant human (rh)PRL, rhIL-3, or both. Cell lysates were subjected to Western blot analysis with anti-STAT-5 and anti-phospho-STAT-5 antibodies. Isolated RNA was subjected to semiquantitative reverse transcriptase polymerase chain reaction analysis of CIS/JAB expression.STAT-5 tyrosine phosphorylation was similarly induced by PRL and IL-3, with an additive effect detected in the presence of both stimuli. Both PRL and IL-3, alone or combined, failed to induce CIS-3 or JAB RNA expression in CD34(+) cells. Interferon-gamma had no effect on CIS-3/JAB induction in these cells. However, CIS-1 was induced by PRLIL-3PRL+IL-3, whereas CIS-2 expression was induced by PRL = IL-3PRL+IL-3.Our findings show that PRL induces activation of STAT-5 and expression of similar CIS/JAB family members as IL-3 does in human CB CD34(+) cells. Because CIS-1 abolishes STAT-5 activation via the IL-3 but not the PRL receptor, the hematopoietic growth-promoting effects of PRL may involve its capacity to provide sustained STAT-5-mediated stimulatory signals to the cells.
Databáze: OpenAIRE